Chengyuan Dong
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Centrosome-related gene SPHK1 drives bladder cancer progression and therapeutic vulnerability.
Journal: Translational oncology
Published: April 22, 2026
Global burden and trends of primary liver cancer are attributable to high BMI among hepatitis B patients: based on the 2021 global burden of disease study.
Journal: International journal of surgery (London, England)
Published: June 30, 2025
Loss of cyclin C drives resistance to anti-TIGIT therapy by upregulating CD155-mediated immune evasion.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: April 17, 2025
CBS promotes tumor immune evasion by reducing MHC-I stability.
Journal: Genes & diseases
Published: February 26, 2025
Integrative Multi-Omics Analysis and Experimental Validation Identify SPOP as a Prognostic Biomarker and Immune Regulator in Lung Adenocarcinoma.
Journal: Journal of Cancer
Published: February 08, 2025
Editorial for the Special Issue on Thin Film Microelectronic Devices and Circuits.
Journal: Micromachines
Published: January 24, 2025
Identification of a novel ferroptosis-related gene signature in hepatocellular carcinoma: clinical significance, tumor microenvironment, drug sensitivity, and gene landscape analysis.
Journal: Discover oncology
Published: December 13, 2024
USP21 stabilizes immune checkpoint of CD276 and serves as an immunological and tumor prognostic biomarker.
Journal: Biochemical and biophysical research communications
Published: October 18, 2024
KLRD1 (CD94): A Prognostic Biomarker and Therapeutic Candidate in Head and Neck Squamous Cell Carcinoma.
Journal: Journal of Cancer
Published: August 01, 2024
Corrigendum to "Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma" [Biochem. Biophys. Res. Commun. 692 (2024), 149344].
Journal: Biochemical and biophysical research communications
Published: July 07, 2024
Senescence Reprogramming by MTHFD2 Deficiency Facilitates Tumor Progression.
Journal: Journal of Cancer
Published: June 02, 2024
Last Updated: 09/26/2026